Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Richard A C Hughes Department of
Neuroimmunology, Guy's Campus, Guy's, King's, and St Thomas's
School of Medicine, London SE1 1UL richard.a.hughes@kcl.ac.uk
| The first 150 words of the full text of this article appear below. |
Peripheral neuropathy is common, often distressing, and sometimes disabling or even fatal. The population prevalence is about 2400 per 100 000 (2.4%), rising with age to 8000 per 100 000 (8%).1 In Europe the commonest cause is diabetes mellitus, which can produce painful neuropathy, disabling foot ulcers, and death from autonomic neuropathy. Leprosy is still prevalent in Africa, India, and South East Asia. This review explains how general practitioners can approach the first level of diagnosis and warn patients about what lies ahead after referral to a specialist.
| Table Removed (Available Only in the Full Text) |
| |
Methods |
|---|
I searched Medline from January 1991 until September 2001 using
the terms "peripheral neuropathy" and "guideline." The search yielded 11 references, including useful guidelines for the diagnosis and management of diabetic peripheral neuropathy,2 but no
guidelines on the diagnosis and management of generic peripheral
neuropathy. This article offers a personal approach to the management
of generalised peripheral neuropathy from the perspective of a
neurologist with a special interest in
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+